Lv2
192 积分 2022-03-18 加入
Megalin and cubilin: multifunctional endocytic receptors
1个月前
已完结
CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes
1个月前
已完结
Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
1个月前
已完结
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
1个月前
已完结
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
4个月前
已完结
Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b study
4个月前
已完结
Implications of frequent hitter E3 ligases in targeted protein degradation screens
5个月前
已完结
TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
5个月前
已完结
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
5个月前
已完结
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
5个月前
已完结
皖公网安备34019202002308
